Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluBlok in healthy adults
NCT00328107Phase 3Completed
- Sponsor
- Protein Sciences
- Start
- Nov 2004
- Primary completion
- Aug 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine, recombinant hemagglutinin in influenza, sponsored by Protein Sciences. Started Nov 2004; status: completed.
02
Drugs
influenza vaccine, recombinant hemagglutinin
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00328107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00328107.